secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001193125-25-180841
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ligand closes $460M 0.75% convertible notes due 2030; net proceeds $445.1M
--------------------------------------------------------------------------

- Issued $460M aggregate principal of 0.75% convertible senior notes due Oct 1, 2030, including $60M greenshoe exercised.
- Initial conversion price ~$194.79/share (32.5% premium over Aug 11 closing price of $147.01).
- Net proceeds ~$445.1M; used $45.9M for convertible note hedge, $15M to repurchase 102,034 shares at $147.01/share.
- Also entered separate warrant transactions covering ~2.36M shares at strike $294.02/share, potentially dilutive.
- Notes may be redeemed at option on/after Oct 6, 2028 if stock >=130% of conversion price for 20 trading days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000119312525180841/0001193125-25-180841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000119312525180841/d939356d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-180841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer